Latest filing published 04 Mar 2021 for Stoke Therapeutics, Inc., €3,933.
Filing timeline
BuySaleInsider track record
Gene Liau: trading record in brief
Gene Liau is a declared insider of Stoke Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 20 December 2019 to 2 March 2021, the count stands at 21 filings.
Every open-market trade on record is a sale: 11 sales worth €2.2M. The rest of the record consists of 10 option exercises. 2021 to date brings no purchases and 3 sales.
The newest entry dates from 4 March 2021: an open-market sale of €153k, in Stoke Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Gene Liau
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,000 shares@ US$0.600.2% of flowCommon StockSEC:0001209191-21-017869:0
- 149 shares@ US$58.730.3% of flowCommon StockSEC:0001209191-21-017869:1
- 5,195 shares@ US$0.600.1% of flowCommon StockSEC:0001209191-21-017869:2
- 2,295 shares@ US$62.46255.1% of flowCommon StockSEC:0001209191-21-017869:3
- 2,900 shares@ US$63.51556.6% of flowCommon StockSEC:0001209191-21-017869:4
- 5,851 shares@ US$0.600.1% of flowCommon StockSEC:0001209191-20-055378:0
- 5,851 shares@ US$40.00039.8% of flowCommon StockSEC:0001209191-20-055378:1
- 30,497 shares@ US$0.600.8% of flowCommon StockSEC:0001209191-20-055378:2
- 1,503 shares@ US$2.190.1% of flowCommon StockSEC:0001209191-20-055378:3
- 24,775 shares@ US$37.641938.9% of flowCommon StockSEC:0001209191-20-055378:4
- 7,225 shares@ US$38.420211.6% of flowCommon StockSEC:0001209191-20-055378:5
- 1,649 shares@ US$0.600.0% of flowCommon StockSEC:0001209191-20-054703:0
- 1,649 shares@ US$40.002.8% of flowCommon StockSEC:0001209191-20-054703:1
- 20,000 shares@ US$2.191.9% of flowCommon StockSEC:0001209191-20-034096:0
- 10,895 shares@ US$25.8212.4% of flowCommon StockSEC:0001209191-20-034096:1
- 7,875 shares@ US$26.919.4% of flowCommon StockSEC:0001209191-20-034096:2
- 1,230 shares@ US$27.481.5% of flowCommon StockSEC:0001209191-20-034096:3
- 7,500 shares@ US$0.600.2% of flowCommon StockSEC:0001209191-20-032149:0
- 7,500 shares@ US$30.0010.1% of flowCommon StockSEC:0001209191-20-032149:1
- 6,000 shares@ US$0.600.2% of flowCommon StockSEC:0001209191-20-024546:0
- 7,500 shares@ US$0.600.2% of flowCommon StockSEC:0001209191-20-024546:1
21 of 21 declarations
